Implantable glucose sensor company Senseonics has launched a remote monitoring app for its users in Europe, the Middle East, and Africa, where its CGM system is distributed by Roche. The app, called Eversense Now, allows users of the sensor to select up to five friends or family members to view their glucose data, which is updated every five minutes. The feature is available for iOS users at the moment, with plans for Android in the works.
from MobiHealthNews http://ift.tt/2og3IZm
February 22, 2018
Rose
MobiHealthNews
No comments
Related Posts:
In human-centric healthcare design, less is moreAmy Schwartz knows that product design isn’t just about making things look pretty. A trained cognitive psychologist, Schwartz said product design is about making devices usable and human-centered. from MobiHealthNews http://… Read More
Wellnicity gets $3.6M for mail-order lab tests, vitaminsWellnicity, an Austin-based company that uses mail-order lab tests to connect people with vitamins and supplements to address particular symptoms, has raised $3.6 million in a new round of funding led by Capstar Partners. fr… Read More
Digital health news briefs for 1/23/18A new technology promises to give users an estimated lens prescription in 10 seconds. PlenOptika, a startup spinout of MIT, uses the auto refractor to measure refractive errors of the eye and produces estimated prescript… Read More
Postoperative wound monitoring app shows potential to reduce readmissionsSending images of surgical wounds to hospital nurses could be an effective way to detect surgical site infections, thereby reducing readmissions, new research shows. And a new smartphone app aims to make that happen… Read More
Clinical trials, management software maker Bio-Optronics draws $30M investmentBio-Optronics — a producer of software and services focused on clinical research, automated scheduling, and patient safety — has announced $30 million in funding from growth equity firm Mainsail Partners. from MobiHealthNews… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment